Dirk Bremen Selected Research

entacapone (Comtan)

5/2007	Entacapone improves complex movement performance in patients with Parkinson's disease.
3/2006	Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels.
3/2006	Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients.
11/2004	Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat.
1/2004	Levodopa therapy with entacapone in daily clinical practice: results of a post-marketing surveillance study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Bremen Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 05/2007 - 01/2004
1	Dyskinesias (Dyskinesia) 11/2004

Drug/Important Bio-Agent (IBA)

5	entacapone (Comtan)FDA Link 05/2007 - 01/2004
4	Levodopa (L Dopa)FDA LinkGeneric 05/2007 - 01/2004
2	Carbidopa (Lodosyn)FDA LinkGeneric 05/2007 - 03/2006
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2006 - 03/2006
1	TabletsIBA 03/2006
1	Dopamine (Intropin)FDA LinkGeneric 11/2004
1	Dopa DecarboxylaseIBA 01/2004
1	TransferasesIBA 01/2004
1	catechol (pyrocatechol)IBA 01/2004

Therapy/Procedure

1	Palliative Care (Palliative Therapy) 11/2004